Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial

Background: Chronic anal fissure is the most prevalent anorectal disorder, characterized by linear or oval ulcers in the anal canal’s squamous epithelium. Although lateral sphincterotomy stands as the gold standard for treatment, chemical sphincterotomy with calcium channel blockers, nitrates, and b...

Full description

Saved in:
Bibliographic Details
Main Authors: Vinoth Sundaresan, Vinothkumar Sadayappan, R Kannan Rajendiran, T Tirou Aroul
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2024-11-01
Series:Journal of Surgical Specialties and Rural Practice
Subjects:
Online Access:https://journals.lww.com/10.4103/jssrp.jssrp_13_24
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1850248277639823360
author Vinoth Sundaresan
Vinothkumar Sadayappan
R Kannan Rajendiran
T Tirou Aroul
author_facet Vinoth Sundaresan
Vinothkumar Sadayappan
R Kannan Rajendiran
T Tirou Aroul
author_sort Vinoth Sundaresan
collection DOAJ
description Background: Chronic anal fissure is the most prevalent anorectal disorder, characterized by linear or oval ulcers in the anal canal’s squamous epithelium. Although lateral sphincterotomy stands as the gold standard for treatment, chemical sphincterotomy with calcium channel blockers, nitrates, and botulinum toxins is favored in the initial stages to avoid surgical side effects. Aim and Objectives: The goal is to assess the efficacy of topical diltiazem in treating chronic fissure in ano, particularly its impact on pain, bleeding, discharge, recurrence rates, and healing compared to the lignocaine–sucralfate combination. Materials and Methods: A prospective, randomized controlled study was conducted at Mahatma Gandhi Medical College and Research Institute, Puducherry, from October 2014 to April 2016, involving 100 cases. Subjects were divided into two groups: Group A received topical 2% diltiazem and Group B was treated with 2% lignocaine and 7% sucralfate. Both groups followed a regimen including a high-fiber diet, sitz baths, and laxatives, with follow-ups at 2, 4, 6 weeks, and 6 months to evaluate treatment outcomes. Results: Significant improvements were noted in Group A, with pain reduction from a mean of 6.48 to 0.48 by the 6th week. Both groups saw enhanced healing rates and reductions in symptoms, with Group A exhibiting a lower recurrence rate, indicating the superior efficacy of 2% diltiazem. Conclusion: Topical 2% diltiazem is more effective in treating chronic anal fissure than the combination of 2% lidocaine gel and 7% sucralfate, offering better pain management, healing rates, and lower recurrence, making it a preferred treatment option.
format Article
id doaj-art-be6e96b1f28e4c5f89e4fa404b62f54b
institution OA Journals
issn 2772-3143
2772-3151
language English
publishDate 2024-11-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Journal of Surgical Specialties and Rural Practice
spelling doaj-art-be6e96b1f28e4c5f89e4fa404b62f54b2025-08-20T01:58:45ZengWolters Kluwer Medknow PublicationsJournal of Surgical Specialties and Rural Practice2772-31432772-31512024-11-0153707410.4103/jssrp.jssrp_13_24Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control TrialVinoth SundaresanVinothkumar SadayappanR Kannan RajendiranT Tirou AroulBackground: Chronic anal fissure is the most prevalent anorectal disorder, characterized by linear or oval ulcers in the anal canal’s squamous epithelium. Although lateral sphincterotomy stands as the gold standard for treatment, chemical sphincterotomy with calcium channel blockers, nitrates, and botulinum toxins is favored in the initial stages to avoid surgical side effects. Aim and Objectives: The goal is to assess the efficacy of topical diltiazem in treating chronic fissure in ano, particularly its impact on pain, bleeding, discharge, recurrence rates, and healing compared to the lignocaine–sucralfate combination. Materials and Methods: A prospective, randomized controlled study was conducted at Mahatma Gandhi Medical College and Research Institute, Puducherry, from October 2014 to April 2016, involving 100 cases. Subjects were divided into two groups: Group A received topical 2% diltiazem and Group B was treated with 2% lignocaine and 7% sucralfate. Both groups followed a regimen including a high-fiber diet, sitz baths, and laxatives, with follow-ups at 2, 4, 6 weeks, and 6 months to evaluate treatment outcomes. Results: Significant improvements were noted in Group A, with pain reduction from a mean of 6.48 to 0.48 by the 6th week. Both groups saw enhanced healing rates and reductions in symptoms, with Group A exhibiting a lower recurrence rate, indicating the superior efficacy of 2% diltiazem. Conclusion: Topical 2% diltiazem is more effective in treating chronic anal fissure than the combination of 2% lidocaine gel and 7% sucralfate, offering better pain management, healing rates, and lower recurrence, making it a preferred treatment option.https://journals.lww.com/10.4103/jssrp.jssrp_13_24chronic fissure in anolidocaine geltopical diltiazemtopical sucralfate
spellingShingle Vinoth Sundaresan
Vinothkumar Sadayappan
R Kannan Rajendiran
T Tirou Aroul
Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
Journal of Surgical Specialties and Rural Practice
chronic fissure in ano
lidocaine gel
topical diltiazem
topical sucralfate
title Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
title_full Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
title_fullStr Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
title_full_unstemmed Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
title_short Topical Diltiazem versus Topical Sucralfate and Lignocaine in the Treatment of Chronic Fissure in Ano: A Prospective Randomized Control Trial
title_sort topical diltiazem versus topical sucralfate and lignocaine in the treatment of chronic fissure in ano a prospective randomized control trial
topic chronic fissure in ano
lidocaine gel
topical diltiazem
topical sucralfate
url https://journals.lww.com/10.4103/jssrp.jssrp_13_24
work_keys_str_mv AT vinothsundaresan topicaldiltiazemversustopicalsucralfateandlignocaineinthetreatmentofchronicfissureinanoaprospectiverandomizedcontroltrial
AT vinothkumarsadayappan topicaldiltiazemversustopicalsucralfateandlignocaineinthetreatmentofchronicfissureinanoaprospectiverandomizedcontroltrial
AT rkannanrajendiran topicaldiltiazemversustopicalsucralfateandlignocaineinthetreatmentofchronicfissureinanoaprospectiverandomizedcontroltrial
AT ttirouaroul topicaldiltiazemversustopicalsucralfateandlignocaineinthetreatmentofchronicfissureinanoaprospectiverandomizedcontroltrial